Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection

OBJECTIVE: To identify potential drug interactions (DIs) between pangenotypic direct-acting antivirals (pDAAs) and concomitant cardiovascular (CV) therapies in patients with chronic hepatitis C (CHC). METHODS: A retrospective observational study was carried out. Patients ≥18 years of age diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sicras-Mainar, Antoni, Morillo-Verdugo, Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645390/
https://www.ncbi.nlm.nih.gov/pubmed/33111612
http://dx.doi.org/10.1177/0300060520964659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645390/
https://www.ncbi.nlm.nih.gov/pubmed/33111612
http://dx.doi.org/10.1177/0300060520964659

Ejemplares similares